Development of a Simple Method for Determining the Absorbed Activity Concentration by the Thyroid Gland of Nuclear Medicine Staff

Document Type : Original Paper


1 Radiation Research Center, Shiraz University, Shiraz, Iran

2 Nuclear Engineering department, School of Mechanical engineering, Shiraz University, Shiraz, Iran

3 Al-Zahra Heart Center, Shiraz University of Medical Sciences, Shiraz, Iran

4 1. Radiation Research Center, Shiraz University, Shiraz, Iran 3. Al-Zahra Heart Center, Shiraz University of Medical Sciences, Shiraz, Iran


Introduction: The occupational safety of nuclear medicine staff working with radioactive iodine (131I) has always been a major concern in nuclear medicine. Since 131I is a volatile substance, it may enter the body during respiration and be absorbed by the thyroid gland of the hospital staff, causing major health problems. This study aimed to develop a simple method for determining the activity concentration of absorbed 131I in the thyroid gland of nuclear medicine staff, using a home-made anthropomorphic neck-thyroid phantom.
Materials and Methods: For this purpose, 131I, with an activity of 370 kBq, was injected inside the thyroid glands of the phantom. The dose rate was measured by placing a portable detector on the thyroid gland at the surface of the neck phantom. The measurements were repeated for two months. Next, a calibration curve was drawn for iodine activity inside the thyroid versus dose rate at the neck surface. The calibration curve was then used to estimate the absorbed activity in the thyroid of the staff in one of the main hospitals of Shiraz, Iran. Finally, a new software program was developed for assessing and recording the activity concentration of 131I accumulated in the thyroid gland. Every day, the dose rate was measured by placing the detector on the neck of the staff. The dose rates were converted to activity concentrations inside the thyroid, using the mentioned calibration curve.
Results: The results indicate that using the calibration factors for every detector, one can have the estimate of the radio-Iodine activity inside the thyroid.
Conclusion: The method proposed in this study can be applied for internal contamination determination in normal working conditions and in accidents.


Main Subjects

  1. Piruzan E, Haghighatafshar M, Faghihi R, Entezarmahdi SM. Calculation of blood dose in patients treated with 131I using MIRD, imaging, and blood sampling methods. Medicine. 2016 Mar;95(11).
  2. Zehtabian M, Dehghan N, Danaei Ghazanfarkhani M, Haghighatafshar M, Sina S. Measurement of the dose to the family members taking care of thyroid cancer patients undergoing I-131 therapy in nuclear medicine using TLD-100. Radiation protection dosimetry. 2017 May 1;174(4):541-4.
  3. Rimpler A, Barth I. Beta radiation exposure of medical staff and implications for extremity dose monitoring. Radiation protection dosimetry. 2007 Jul 1;125(1-4):335-9. DOI: 10.1093/rpd/ncl384.
  4. Kemerink GJ, Franssen R, Visser MG, Urbach CJ, Halders SG, Frantzen MJ, et al. Hard beta and gamma emissions of 124I. Impact on occupational dose in PET/CT. Nuklearmedizin. 2011;50(6).
  5. Aubert B, Guilabert N, Lamon A, Richard M. Which protection against radiation for new protocols of internal radiotherapy by Yttrium 90? Proceedings of the 6th European ALARA Network Workshop “Occupational Exposure Optimisation in the Medical Field and Radiopharmaceutical Industry”, Madrid. 2002; 47–9.
  6. International Atomic Energy Agency (IAEA). Assessment of Occupational Exposure Due to Intakes of Radionuclides. Safety Standards Series No. RS-G-1.2, IAEA, Vienna,Austria. 1999.
  7. International Commission on Radiological Protection. Individual Monitoring for Internal Exposure of Workers. ICRP Publication 78 Elsevier, UK. 1998.
  8. International Atomic Energy Agency (IAEA). Direct methods for measuring radionuclides in the human body. Safety Series no. 114 IAEA, Vienna, Austria. 1996.
  9. International Atomic Energy Agency (IAEA). Indirect Methods for assessing intakes of radionuclides causing occupational exposure. Safety Reports Series no. 18 IAEA,Vienna, Austria. 2000.
  10. Mehdizadeh Naderi S, Sina S, Karimipoorfard M, Lotfalizadeh F, Entezarmahdi M, Moradi H, et al. Design and fabrication of a multipurpose thyroid phantom for medical dosimetry and calibration. Radiation protection dosimetry. 2016 Mar 1;168(4):503-8.
  11. Karimi M, Mostaghimi H, Shams SF, Mehdizadeh AR. Design and Production of Two-piece Thyroid-neck Phantom by the Concurrent Use of Epoxy Resin and Poly (methyl methacrylate) Soft Tissue Equivalent Materials. Journal of biomedical physics & engineering. 2018 Jun;8(2):217.
  12. Amin NB, Abualroos NJ, Zainon R. Fabrication of anthropomorphic thyroid-neck phantom for dosimetry study in nuclear medicine. Radiation Physics and Chemistry. 2020 Jan 1; 166:108462.
  13. Dantas BM, Lucena EA, Dantas AL, Araujo F, Rebelo AM, Teran M, et al. A protocol for the calibration of gamma cameras to estimate internal contamination in emergency situations. Radiation protection dosimetry. 2007 Nov 1;127(1-4):253-7.
  14. Vidal MV, Dantas AL, Dantas BM. A methodology for auto-monitoring of internal contamination by 131I in nuclear medicine workers. Radiation Protection Dosimetry. 2007 Jul 1;125(1-4):483-7.
  15. Franck D, Berniere J, Viltard D, Parre F, Challeton-de Vathaire C, et al. Development of two mobile laboratories for a routine and accident monitoring of internal contamination. Applied Radiation and Isotopes. 2012 Jul 1;70(7):1095-9.
  16. Cerqueira RA, Maia AF. Development of thyroid anthropomorphic phantoms for use in nuclear medicine. Radiation Physics and Chemistry. 2014 Feb 1; 95:174-6. DOI:10.1016/j.radphyschem.201212.038i.
  17. Hermosilla A, Diaz Londono G, Garcia M, Ruiz F, Andrade P, Perez A. Design and manufacturing of anthropomorphic thyroid-neck phantom for use in nuclear medicine centres in Chile. Radiation protection dosimetry. 2014 Dec 1;162(4):508-14.
  18. International atomic energy agency (IAEA). Safety Series No. 115, Vienna. 1996.
  19. International atomic energy agency (IAEA). Safety Report Series No.40, Vienna. 2005.
Volume 18, Issue 3
May and June 2021
Pages 211-217
  • Receive Date: 06 August 2019
  • Revise Date: 04 July 2020
  • Accept Date: 17 July 2020
  • First Publish Date: 01 May 2021